Want to see IN:WINDLAS full AI Analyst Report?
Windlas Biotech Ltd. (WINDLAS) Financial Statements
Windlas Biotech Ltd. Financial Overview
Windlas Biotech Ltd.'s market cap is currently $18.10B. The company's EPS TTM is $31.73; its P/E ratio is 27.61; and it has a dividend yield of 0.72%. Windlas Biotech Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 9.04B | $ 7.60B | $ 6.29B | $ 5.11B | $ 4.63B |
| Gross Profit | $ 1.64B | $ 2.88B | $ 2.28B | $ 1.81B | $ 1.61B |
| Operating Income | $ 739.99M | $ 661.22M | $ 652.21M | $ 479.24M | $ 402.76M |
| EBITDA | $ 1.05B | $ 1.12B | $ 916.40M | $ 701.91M | $ 591.29M |
| Net Income | $ 664.56M | $ 609.94M | $ 581.87M | $ 426.26M | $ 380.89M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.70B | $ 2.40B | $ 2.04B | $ 1.32B | $ 1.76B |
| Total Assets | $ 9.07B | $ 7.60B | $ 6.26B | $ 5.29B | $ 4.91B |
| Total Debt | $ 352.42M | $ 325.97M | $ 36.41M | $ 49.93M | $ 66.37M |
| Net Debt | $ 334.28M | $ 321.73M | $ -16.47M | $ 13.07M | $ 60.67M |
| Total Liabilities | $ 3.27B | $ 2.55B | $ 1.76B | $ 1.27B | $ 962.33M |
| Stockholders' Equity | $ 5.81B | $ 5.06B | $ 4.50B | $ 4.02B | $ 3.95B |
| Cash Flow | |||||
| Free Cash Flow | $ 337.68M | $ 159.93M | $ 712.76M | $ -99.25M | $ -56.74M |
| Operating Cash Flow | $ 1.01B | $ 681.87M | $ 1.09B | $ 609.65M | $ 91.30M |
| Investing Cash Flow | $ -931.15M | $ -740.64M | $ -920.68M | $ -141.10M | $ -1.55B |
| Financing Cash Flow | $ -82.06M | $ 10.13M | $ -152.90M | $ -437.39M | $ 1.30B |
Currency in INR